Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.
Haji S, Fujita K, Oki R, Osaki Y, Miyamoto R, Morino H, Nagano S, Atsuta N, Kanazawa Y, Matsumoto Y, Arisawa A, Kawai H, Sato Y, Sakaguchi S, Yagi K, Hamatani T, Kagimura T, Yanagawa H, Mochizuki H, Doyu M, Sobue G, Harada M, Izumi Y. Haji S, et al. Among authors: sakaguchi s. JMIR Res Protoc. 2023 Jan 30;12:e42032. doi: 10.2196/42032. JMIR Res Protoc. 2023. PMID: 36716091 Free PMC article.
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: sakaguchi s. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
Research Ethics Consultation in Nursing Studies.
Kane C, Sakaguchi S, Chuma M, Yagi K, Takechi K, Aoe Y, Takagai T, Yanagawa H. Kane C, et al. Among authors: sakaguchi s. J Empir Res Hum Res Ethics. 2022 Feb-Apr;17(1-2):63-69. doi: 10.1177/15562646211036577. Epub 2021 Aug 10. J Empir Res Hum Res Ethics. 2022. PMID: 34374568
A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic.
Yagi K, Sato Y, Sakaguchi S, Goda M, Hamano H, Aizawa F, Shimizu M, Inoue-Hamano A, Nishimori T, Tagi M, Kanno M, Matsuoka-Ando R, Yoshioka T, Matstubara Y, Izawa-Ishizawa Y, Shimizu R, Maruo A, Kuniki Y, Sakamoto Y, Itobayashi S, Zamami Y, Yanagawa H, Ishizawa K. Yagi K, et al. Among authors: sakaguchi s. Educ Inf Technol (Dordr). 2022;27(7):10371-10386. doi: 10.1007/s10639-022-11032-5. Epub 2022 Apr 18. Educ Inf Technol (Dordr). 2022. PMID: 35464114 Free PMC article.
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells.
Ando-Matsuoka R, Yagi K, Takaoka M, Sakajiri Y, Shibata T, Sawada R, Maruo A, Miyata K, Aizawa F, Hamano H, Niimura T, Izawa-Ishizawa Y, Goda M, Sakaguchi S, Zamami Y, Yamanishi Y, Ishizawa K. Ando-Matsuoka R, et al. Among authors: sakaguchi s. Drug Dev Res. 2023 Feb;84(1):75-83. doi: 10.1002/ddr.22013. Epub 2022 Dec 9. Drug Dev Res. 2023. PMID: 36484282
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Hanibuchi M, Kakiuchi S, Atagi S, Ogushi F, Shimizu E, Haku T, Toyoda Y, Azuma M, Kondo M, Kawano H, Otsuka K, Sakaguchi S, Nokihara H, Goto H, Nishioka Y. Hanibuchi M, et al. Among authors: sakaguchi s. Lung Cancer. 2018 Nov;125:93-99. doi: 10.1016/j.lungcan.2018.09.007. Epub 2018 Sep 12. Lung Cancer. 2018. PMID: 30429044 Clinical Trial.
1,197 results